The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 12.50
Ask: 13.50
Change: 5.575 (75.08%)
Spread: 1.00 (8.00%)
Open: 9.65
High: 13.50
Low: 9.65
Prev. Close: 7.425
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

15 Oct 2015 07:00

RNS Number : 3109C
Carclo plc
15 October 2015
 

15 October 2015

 

Carclo plc

("Carclo" or "the Group")

 

Half year trading update

 

The Board is pleased to announce that Carclo has traded well ahead of the comparative period last year and in line with its expectations for the first half of the financial year. 

 

In Technical Plastics, profits will be ahead of last year's comparative period despite the impact of the weaker Euro on some of our businesses. Our new state of the art Chinese facility in Taicang is now complete and attracting interest from existing and potential new customers and we remain on track to integrate all local activities into the new site prior to the year end. We have continued to develop the Group's site infrastructure and are now close to finalising plans to double the size of our Bangalore, India facility in expectation of significant growth in this market. New business development throughout the division has continued to progress well and we believe this will drive growth over the coming years.

 

In LED Technologies, new programme wins in the first half have been in line with expectations and lighting product sales have been strong. We have also secured a flagship vehicle programme for a new major customer and we see significant potential over the next few years to develop this relationship. Whilst this progress is encouraging, one of our other major Group customers, the VW Group ("VW"), this week announced that its flagship luxury vehicle which was due for launch in 2017 will now be launched as an all-electric vehicle. While the full ramifications of this decision on the lighting design are not yet confirmed, we anticipate that this announcement will impact the expected launch date of this vehicle and therefore the timing of anticipated related revenues for our Wipac business.

 

As previously highlighted the Precision Engineering division will report operating profits a little behind last year's comparative period due to weakness in the spares segment order book. There are some signs of a strengthening of our order book in this division as we enter the second half.

 

Carclo Diagnostic Solutions has continued to meet its development timelines. During the period we have been able to generate excellent technical data on the performance of our Micropoc platform and this will be shown to potential collaborators at forthcoming medical conferences. We have now commissioned a healthcare practitioner review of the Micropoc platforms and intended applications as part of the Board's strategy to continually evaluate the strength of the opportunity given our continued investment in this area.

 

The financial position of the Group remains strong. Group debt has increased at the half year, as anticipated following the investment in China, but is expected to decrease from this level by the end of the financial year.

 

The Board anticipates that the likely impact of the announcement from VW will mean the Group's full year performance will be marginally below its previous expectations.

 

Carclo plc will announce its interim results for the period to 30 September 2015 on 17 November 2015.

- ENDS -

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

 

Note to Editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the group has been investing in lower cost regions and new technologies.

 

Approximately three fifths of revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFERIALSLIE
Date   Source Headline
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.